Eolo Pharma
Wilmington
About Eolo Pharma
Pharma develops molecular drugs intended to cure chronic inflammation. It specializes in the research and development of medicines that target the molecular and cellular basis of inflammation-related diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $4.5M
- Last round: Series Unknown (Feb 2023)
- Website: eolo-pharma.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/eolo-pharma-78932 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.